Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder

Abstract

Persons diagnosed with schizophrenia (SCZ) or bipolar I disorder (BPI) are at high risk for self-injurious behavior, suicidal ideation, and suicidal behaviors (SB). Characterizing associations between diagnosed health problems, prior pharmacological treatments, and polygenic scores (PGS) has potential to inform risk stratification. We examined self-reported SB and ideation using the Columbia Suicide Severity Rating Scale (C-SSRS) among 3,942 SCZ and 5,414 BPI patients receiving care within the Veterans Health Administration (VHA). These cross-sectional data were integrated with electronic health records (EHRs), and compared across lifetime diagnoses, treatment histories, follow-up screenings, and mortality data. PGS were constructed using available genomic data for related traits. Genome-wide association studies were performed to identify and prioritize specific loci. Only 20% of the veterans who reported SB had a corroborating ICD-9/10 EHR code. Among those without prior SB, more than 20% reported new-onset SB at follow-up. SB were associated with a range of additional clinical diagnoses, and with treatment with specific classes of psychotropic medications (e.g., antidepressants, antipsychotics, etc.). PGS for externalizing behaviors, smoking initiation, suicide attempt, and major depressive disorder were associated with SB. The GWAS for SB yielded no significant loci. Among individuals with a diagnosed mental illness, self-reported SB were strongly associated with clinical variables across several EHR domains. Analyses point to sequelae of substance-related and psychiatric comorbidities as strong correlates of prior and subsequent SB. Nonetheless, past SB was frequently not documented in health records, underscoring the value of regular screening with direct, in-person assessments, especially among high-risk individuals.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Phenotypic correlations for C-SSRS and EHR-based ratings of suicidality.
Fig. 2: PheWAS for suicidality phenotypes in CSP #572.
Fig. 3: Associations of self-reported suicidality with pharmacological treatment history.
Fig. 4: Associations of PGS with suicidality behaviors in SCZ and BPI.
Fig. 5: Comparisons with follow-up screenings for suicidality, mortality, and attributed cause of death.

Similar content being viewed by others

Data availability

All data sources are described in the manuscript and supplemental information. No new data were collected. Only data from existing cohorts of VA participants were analyzed, which have restricted access to protect the privacy of the study participants. The process for obtaining the GWAS summary statistics used in these analyses are described in the corresponding original GWAS publications.

Code availability

No custom algorithms or software was developed in this study. All code is available by request from the corresponding author. All primary analyses completed in R 4.2.2.

References

  1. Wisqars W-BISQ. Reporting system. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (producer) https://www.cdc.gov/injury/wisqars/ Accessed September. 2020;25

  2. Thompson M, Gibbs N. More U.S. soldiers have killed themselves than have died in the Afghan war. Why can’t the Army win the war on suicide? Time. 2012;180:22–31.

    PubMed  Google Scholar 

  3. Tilstra AM, Simon DH, Masters RK. Trends in ‘deaths of despair’ among working-aged White and Black Americans, 1990–2017. Am J Epidemiol. 2021;190:1751–9.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bachmann S. Epidemiology of suicide and the psychiatric perspective. Int J Environ Res Public Health. 2018;15:1425.

  5. Bridge JA, Horowitz LM, Fontanella CA, Sheftall AH, Greenhouse J, Kelleher KJ, et al. Age-related racial disparity in suicide rates among US youths from 2001 through 2015. JAMA Pediatr. 2018;172:697–9.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mullins N, Bigdeli TB, Børglum AD, Coleman JRI, Demontis D, Mehta D, et al. GWAS of suicide attempt in psychiatric disorders and association with major depression polygenic risk scores. Am J Psychiatry. 2019;176:651–60.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Levey DF, Polimanti R, Cheng Z, Zhou H, Nuñez YZ, Jain S, et al. Genetic associations with suicide attempt severity and genetic overlap with major depression. Transl Psychiatry. 2019;9:22.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ruderfer DM, Walsh CG, Aguirre MW, Tanigawa Y, Ribeiro JD, Franklin JC, et al. Significant shared heritability underlies suicide attempt and clinically predicted probability of attempting suicide. Mol Psychiatry. 2020;25:2422–30.

    Article  PubMed  Google Scholar 

  9. Docherty AR, Shabalin AA, DiBlasi E, Monson E, Mullins N, Adkins DE, et al. Genome-wide association study of suicide death and polygenic prediction of clinical antecedents. Am J Psychiatry. 2020;177:917–27.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Karlsson Linnér R, Mallard TT, Barr PB, Sanchez-Roige S, Madole JW, Driver MN, et al. Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction. Nat Neurosci. 2021;24:1367–76.

    Article  PubMed  Google Scholar 

  11. Gaziano JM, Concato J, Brophy M, Fiore L, Pyarajan S, Breeling J, et al. Million veteran program: a mega-biobank to study genetic influences on health and disease. J Clin Epidemiol. 2016;70:214–23.

    Article  PubMed  Google Scholar 

  12. Harvey PD, Siever LJ, Huang GD, Muralidhar S, Zhao H, Miller P, et al. The genetics of functional disability in schizophrenia and bipolar illness: methods and initial results for VA cooperative study# 572. Am J Med Genet B Neuropsychiatr Genet. 2014;165:381–9.

    Article  CAS  Google Scholar 

  13. Posner K, Brent D, Lucas C, Gould M, Stanley B, Brown G, et al. Columbia-suicide severity rating scale. New York, NY: Columbia University; 2008.

  14. Bigdeli T, Fanous A, Li Y, Rajeevan N, Sayward F, Zhao H, et al. Genome-wide association studies of schizophrenia and bipolar disorder in a diverse cohort of US veterans. Biol Psychiatry. 2020;87:S178.

    Article  Google Scholar 

  15. Harvey PD, Posner K, Rajeevan N, Yershova KV, Aslan M, Concato J. Suicidal ideation and behavior in US veterans with schizophrenia or bipolar disorder. J Psychiatr Res. 2018;102:216–22.

    Article  PubMed  Google Scholar 

  16. Aslan M, Radhakrishnan K, Rajeevan N, Sueiro M, Goulet JL, Li Y, et al. Suicidal ideation, behavior, and mortality in male and female US veterans with severe mental illness. J Affect Disord. 2020;267:144–52.

    Article  PubMed  Google Scholar 

  17. First MB, Spitzer RL, Gibbon M, Williams JBW User’s guide for the Structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version. American Psychiatric Pub; Washington, DC 1997.

  18. Posner K, Brent D, Lucas C, Gould M, Stanley B, Brown G, et al. Columbia-suicide severity rating scale (C-SSRS), vol 10. New York, NY: Columbia University Medical Center; 2008.

  19. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–33.

    PubMed  Google Scholar 

  20. Ashley-Koch AE, Kimbrel NA, Qin XJ, Lindquist JH, Garrett ME, Dennis MF, et al. Genome-wide association study identifies four pan-ancestry loci for suicidal ideation in the Million Veteran Program. PLoS Genet. 2023;19:e1010623.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kimbrel NA, Ashley-Koch AE, Qin XJ, Lindquist JH, Garrett ME, Dennis MF, et al. A genome-wide association study of suicide attempts in the million veterans program identifies evidence of pan-ancestry and ancestry-specific risk loci. Mol Psychiatry. 2022;27:2264–72.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Liao KP, Sun J, Cai TA, Link N, Hong C, Huang J, et al. High-throughput multimodal automated phenotyping (MAP) with application to PheWAS. J Am Med Inf Assoc. 2019;26:1255–62.

    Article  Google Scholar 

  23. Denny JC, Ritchie MD, Basford MA, Pulley JM, Bastarache L, Brown-Gentry K, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations. Bioinformatics. 2010;26:1205–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Bigdeli TB, Voloudakis G, Barr PB, Gorman BR, Genovese G, Peterson RE, et al. Penetrance and pleiotropy of polygenic risk scores for schizophrenia, bipolar disorder, and depression among adults in the US veterans affairs health care system. JAMA Psychiatry. 2022;79:1092–101.

  25. Klarin D, Damrauer SM, Cho K, Sun YV, Teslovich TM, Honerlaw J, et al. Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. Nat Genet. 2018;50:1514–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. 1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68–74.

    Article  Google Scholar 

  27. Das S, Forer L, Schönherr S, Sidore C, Locke AE, Kwong A, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48:1284–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen W-M. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26:2867–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Fang H, Hui Q, Lynch J, Honerlaw J, Assimes TL, Huang J, et al. Harmonizing genetic ancestry and self-identified race/ethnicity in genome-wide association studies. Am J Hum Genet. 2019;105:763–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Bigdeli TB, Genovese G, Georgakopoulos P, Meyers JL, Peterson RE, Iyegbe CO, et al. Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry. Mol Psychiatry. 2019. https://doi.org/10.1038/s41380-019-0517-y.

  31. Peterson RE, Kuchenbaecker K, Walters RK, Chen C-Y, Popejoy AB, Periyasamy S, et al. Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations. Cell. 2019;179:589–603.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Abraham G, Inouye M. Fast principal component analysis of large-scale genome-wide data. PLoS One. 2014;9:e93766.

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  33. Mullins N, Kang J, Campos AI, Coleman JRI, Edwards AC, Galfalvy H, et al. Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders and known risk factors. Biol Psychiatry. 2021. https://doi.org/10.1016/j.biopsych.2021.05.029.

  34. Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–8.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  35. Nievergelt CM, Maihofer AX, Klengel T, Atkinson EG, Chen C-Y, Choi KW, et al. International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci. Nat Commun. 2019;10:4558.

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  36. Mullins N, Forstner AJ, O’Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Howard DM, Adams MJ, Clarke T-K, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22:343–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, et al. Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet. 2019;51:237–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018;50:912–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011;88:294–305.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88:76–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Schizophrenia Working Group of the Psychiatric Genomics, Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.

    Article  ADS  Google Scholar 

  46. Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  47. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Lee CH, Eskin E, Han B. Increasing the power of meta-analysis of genome-wide association studies to detect heterogeneous effects. Bioinformatics. 2017;33:i379–i388.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Gamazon ER, Wheeler HE, Shah KP, Mozaffari SV, Aquino-Michaels K, Carroll RJ, et al. A gene-based association method for mapping traits using reference transcriptome data. Nat Genet. 2015;47:1091–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Barbeira, Dickinson AN, Bonazzola SP, Zheng R, Wheeler HE J, Torres JM, et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018;9:1825.

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  51. Martin AR, Gignoux CR, Walters RK, Wojcik GL, Neale BM, Gravel S, et al. Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations. Am J Hum Genet. 2017;100:635–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Duncan L, Shen H, Gelaye B, Meijsen J, Ressler K, Feldman M, et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019;10:3328.

  53. Gujral K, Bahraini N, Brenner LA, Van Campen J, Zulman DM, Illarmo S, et al. VA’s implementation of universal screening and evaluation for the suicide risk identification program in November 2020 -Implications for Veterans with prior mental health needs. PLoS ONE. 2023;18:e0283633.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. DailyMed - CLOZAPINE tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=883b5d43-0339-7dc1-f775-93791fb9b978. Accessed 28 Oct 2022.

  55. Barr PB, Neale Z, Schulman J, Mullins N, Zhang J, Chorlian DB, et al. Clinical, genomic, and neurophysiological correlates of lifetime suicide attempts among individuals with alcohol dependence. medRxiv. 2023. https://doi.org/10.1101/2023.04.28.23289173.

  56. Colbert SMC, Mullins N, Chan G, Meyers JL, Schulman J, Kuperman S, et al. Polygenic contributions to suicidal thoughts and behaviors in a sample ascertained for alcohol use disorders. Complex Psychiatry. 2023;9:11–23.

  57. Lim KX, Rijsdijk F, Hagenaars SP, Socrates A, Choi SW, Coleman JRI, et al. Studying individual risk factors for self-harm in the UK Biobank: a polygenic scoring and Mendelian randomisation study. PLoS Med. 2020;17:e1003137.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Pardiñas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50:381–9.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Wegscheid ML, Anastasaki C, Hartigan KA, Cobb OM, Papke JB, Traber JN, et al. Patient-derived iPSC-cerebral organoid modeling of the 17q11.2 microdeletion syndrome establishes CRLF3 as a critical regulator of neurogenesis. Cell Rep. 2021;36:109315.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet. 2018;50:1112–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50:668–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Blosnich JR, Montgomery AE, Dichter ME, Gordon AJ, Kavalieratos D, Taylor L, et al. Social determinants and military veterans’ suicide ideation and attempt: a cross-sectional analysis of electronic health record data. J Gen Intern Med. 2020;35:1759–67.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported by the Department of Veterans Affairs Cooperative Studies Program (CSP #572), the Million Veteran Program (MVP-000) and a Clinical Sciences Research and Development award (lK6BX003777). The MVP is supported by the Office of Research and Development, Department of Veterans Affairs. Full acknowledgements for CSP #572 and MVP are presented in the Supplement. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. TBB was supported by a 2019 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (#28276). This analysis uses data from the Externalizing Consortium, supported by the National Institute on Alcohol Abuse and Alcoholism (R01AA015416), and the National Institute on Drug Abuse (R01DA050721). Additional funding for investigator effort has been provided by K02AA018755, U10AA008401, P50AA022537, and a European Research Council Consolidator Grant (647648 EdGe). The content does not necessarily represent the views of these funding bodies. We would also like to thank the participants and employees of 23andMe, Inc. for making this work possible. We are grateful to Drs. R. Karlsson Linnér and T.T. Mallard for sharing their script for plotting PheWAS results. LJS, original co-Principal Investigator for CSP #572, passed away in February 2021.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

TBB, MA and PDH conceived the study. PDH and MA oversaw the study. TBB and PBB were the lead analysts. TBB, PBB, NR, AHF, MA and PDH were involved in interpretation of results. TB. and PBB led the writing of the manuscript, with substantive contributions to the writing from PDH and MA. All authors contributed to and critically reviewed the manuscript.

Corresponding author

Correspondence to Tim B. Bigdeli.

Ethics declarations

Competing interests

PDH has served as a consultant to multiple pharmaceutical companies and device manufacturers on phase 2 or 3 development; this consulting work has been determined to be unrelated to the content of the paper. No other authors report any relevant conflicts of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bigdeli, T.B., Barr, P.B., Rajeevan, N. et al. Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02472-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41380-024-02472-1

Search

Quick links